$FHTX

Foghorn Therapeutics Inc

  • NASDAQ
  • Health Technology
  • Biotechnology

PRICE

$8.45 ▲4.321%

Extented Hours

VOLUME

62,584

DAY RANGE

7.665 - 8.2499

52 WEEK

4.51 - 18.12

Join Discuss about FHTX with like-minded investors

AL
@albertoc #StockTraders.NET
recently

$FHTX on watch swipe before market close

85 Replies 11 👍 7 🔥

SO
@soheil.n #StockTraders.NET
recently

Watchlist: $PFE - short: hoping for a push towards 61-61.5 $BLU - long: will start in around 8.1 and add towards 8.2 $FHTX - long: break over 18.2-18.4 $SGMA - long: base over 13 for confirmation $SPRB - 4 m FL - looking for 3.3-3.5 for a short $GNFT - 45 m FL - looking for the whole #, 5 magnet

114 Replies 13 👍 8 🔥

SO
@soheil.n #StockTraders.NET
recently

Watchlist: $BLU - long: waiting for 8s to base f1st and then 8.2-.3s or the move higher $SEAC - inside day. Long: once 1.7-.7s firms up. Short: if it stays heavy under 1.45s $CFVI - long: if 12s bases. Short: if it tops out and rejects 12.8-13s $SGMA - long: waiting to see if 13 bases for pus higher $FHTX - long: for 18 to base. Short: for 17 to top out $PFE - short: a push towards the highs 59.5 to short

63 Replies 12 👍 9 🔥

SO
@soheil.n #StockTraders.NET
recently

$SGMA - not sure if it will hold though ...similar move like $FHTX

131 Replies 9 👍 10 🔥

AL
@albertoc #StockTraders.NET
recently

$FHTX kind of the type of set up I was looking for in $BLU Will wait on higher low consolidation in $BLU of volume picking up

142 Replies 13 👍 12 🔥

SO
@soheil.n #StockTraders.NET
recently

going for the breakout...the stock is ...not me :) > @soheil.n said: $FHTX - alerts hit...volume comin gin

89 Replies 15 👍 9 🔥

SO
@soheil.n #StockTraders.NET
recently

$FHTX - alerts hit...volume comin gin

143 Replies 7 👍 12 🔥

profile
@maletone #StockTraders.NET
recently

watch list: $PTPI, $BLU, $FHTX, $SEAC, $SGMA, $EFOI

62 Replies 12 👍 9 🔥

Key Metrics

Market Cap

330.83 M

Beta

1.39

Avg. Volume

95.68 K

Shares Outstanding

41.82 M

Yield

0%

Public Float

0

Next Earnings Date

2023-08-08

Next Dividend Date

Company Information

foghorn therapeutics inc., a biopharmaceutical company, discovers and develops medicines targeting genetically determined dependencies within the chromatin regulatory system. the company uses its proprietary gene traffic control platform to identify, validate, and potentially drug targets within the system. it is developing fhd-286, a small-molecule enzymatic inhibitor of brg1 and brm for the treatment of acute myeloid leukemia and uveal melanoma; and fhd-609, a small molecule protein degrader of brd9 to treat patients with synovial sarcoma. the company is also developing preclinical and discovery programs, including selective brm targeting non-small-cell lung cancer; and selective arid1b modulators for bladder, ovarian, and endometrial cancer. it has a collaboration with merck sharp & dohme corp. to discover and develop novel oncology therapeutics against a transcription factor target. the company was founded in 2015 and is headquartered in cambridge, massachusetts.

Website:

HQ: ,

Related News